3 Falling Stock to Think About Selling Short Right Now

Worries about sky-high inflation, the Federal Reserve’s hawkish stance, and recession prospects have spurred market sell-off lately. Moreover, investors expect increased market volatility as analysts cut down their earnings estimates….

Cathie Wood Doubled Down on This Biotech Stock, Should You?

Biotech company Ginkgo Bioworks’ (DNA) top-line growth didn’t translate into bottom-line improvement in its last quarter. The stock is currently trading approximately 84% below its 52-week high, and analysts expect…

3 Stocks to Prepare Your Portfolio for the Next Black Swan Event

Black swan events are world-changing events that are rare and unpredictable and have outcomes with devastating effects. These events have severe implications for financial markets and investment portfolios. While investors…

Cathie Wood Is Building up Her Stake in This Stock. Should You?

Digital health company Butterfly Network (BFLY) reported a year-over-year increase in revenue in the last quarter, but its bottom line declined significantly. Moreover, its near-term prospects look bleak as analysts…

Should Investors Buy the Dip on This Digital Payment Stock?

Digital payments company PayPal (PYPL) reported nearly 10% year-over-year revenue growth in the fiscal 2022 second quarter. However, the company’s top-line growth did not translate into bottom-line improvement. Moreover, shares…

Twitter Stock Was A “Sell” Even Before Whistleblower Revealed Security Issues

Social media company Twitter (TWTR) has been experiencing a rough time. In addition to poor second-quarter performance, TWTR is fighting a legal battle with Elon Musk over his decision to…

Bill Gates Adding to Ecolab Position, but 3 of His Holdings Are Better Buys

Microsoft co-founder and philanthropist Bill Gates’ Bill & Melinda Gates Foundation has a substantial portfolio of investments, which several investors keenly follow. Bill Gates has been recently buying shares of…